Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Novartis India

Sector: Healthcare | Industry: Drugs & Pharma
R 637.95 30.00  | 4.93% -7.80% 35.39 1,506.14
BSE Price: Oct 22, 11:03 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 22, 11:03 637.95 30.00 4.93% 615.00 607.95 3,210 605.25 - 650.10
NSE Apr 30, 2003 217.15 -1.70 -0.78% 219.80 218.85 31,229 216.10 - 220.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 20,225 P/B: 1.97 NSE Code: NOVARTIND
52-Week Range: R 558.00 - 789.90 Dividend Yield: 1.64% BSE Code: 500672
TTM EPS: R 17.24 Book Value: R 309.52 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Novartis India -15.60 -3.36 -9.20 -17.13 -3.67 -0.80 0.58
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -12.98 -10.73 -10.66
Net Profit -33.93 -36.09 -12.08
EPS -33.93 -30.34 -7.41
Book Value 3.19 -6.27 0.56
Average
Operating Margin 18.45 20.82 22.85
Net Margin 9.10 9.19 11.37
Return on Networth 6.89 7.22 9.55
Return on Investment 11.70 13.39 14.89
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -0.97 -20.85 -0.97
Operating Profit -82.91 -69.70 -82.91
Net Profit -95.95 -92.10 -95.95
EPS -95.95 -92.10 -95.95
TTM
Revenue -5.87 -21.34 -5.87
Operating Profit -14.46 -55.43 -14.46
Net Profit -17.79 -47.67 -17.79
EPS -17.79 -43.86 -17.79
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Novartis India 1,506.14 461.89 42.56 8.05 6.89 1.97 35.39
Astrazeneca Pharma India 5,825.00 771.42 69.56 8.84 20.03 18.19 83.74
Eris Lifesciences 5,775.83 1,005.70 303.64 29.29 28.96 4.68 19.03
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jan 23, 2018 Novartis A G  Sell Buy-back Offer 3,205,362 664.55 21,301.23
Sep 16, 2016 Novartis AG  Sell - 23,970,597 727.55 174,398.08
May 30, 2013 Novartis AG  Sell Market 454,205 579.50 2,632.12
Fund Houses invested in the stock
Fund Jun-17 Mar-17 Dec-16 Sep-16 Jun-16
Sundaram Mutual Fund 0.289 0.314 0.314 0.314 0.321
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Novartis India Ltd.

Address: The Inspire B K C, Part Of 601 & 701, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra - 400051 | Phone: 022-24958400 / 24958888 | Fax: 022-24950221

Email: [email protected]

Website: www.novartis.in

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
1.93
Piotroski F-Score
4
Modified C-Score
3
5-Years Price to Earnings
35.27
5-Years Price to Book
1.96
Earnings Yield
EBIT / Enterprise value
8.07%
PEG
Price / Earnings to growth ratio
-2.27
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,377.45 +4.35%
Caplin Point Laboratories R391.80 -1.27%
Eris Lifesciences R420.05 -0.60%
FDC R160.30 -0.37%
JB Chemicals & Pharma R363.65 -0.79%
Laurus Labs R329.00 +4.05%
Strides Pharma Science R349.00 -1.37%
Sun Pharma Adv. Research R132.30 -0.15%
Suven Life Sciences R283.85 +1.18%
Wockhardt R275.30 +3.32%
As on Oct 22, 10:54